Molecular Imaging of Cardiac Sarcoidosis

被引：14

作者：

Martineau P. ^{[1
]}

Pelletier-Galarneau M. ^{[2
,3
]}

Juneau D. ^{[4
]}

Leung E. ^{[1
]}

Birnie D. ^{[5
]}

Beanlands R.S.B. ^{[5
]}

机构：

[1] Division of Nuclear Medicine, Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON

[2] Department of Radiology and Nuclear Medicine, Montreal Heart Institute, Montreal, QC

[3] Gordon Center for Medical Imaging, Massachusetts General Hospital, Boston, MA

[4] Department of Radiology and Nuclear Medicine, University of Montreal, Montreal, QC

[5] Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute (UOHI), Ottawa, ON

来源：

Current Cardiovascular Imaging Reports | 2018年 / 11卷 / 3期

关键词：

Cardiac PET imaging; Cardiac sarcoidosis; FDG-PET imaging; [!sup]18[!/sup]F]-deoxyglucose;

D O I：

10.1007/s12410-018-9446-4

中图分类号：

学科分类号：

摘要：

Purpose of Review: Cardiac involvement is increasingly being recognized as a cause of significant morbidity and mortality in patients with sarcoidosis. Unfortunately, imaging cardiac sarcoidosis (CS) remains a challenge and often relies on advanced imaging modalities. The aim of this review is to provide an up-to-date overview of the role of molecular imaging for the diagnosis of cardiac sarcoidosis, with particular emphasis on the use of FDG and non-FDG PET. Recent Findings: In the last few years, FDG-PET has established itself as an accurate imaging study for the assessment of CS. New diagnostic criteria have recently appeared which incorporate FDG-PET findings in the diagnostic workup for CS. In addition, a joint SNMMI-ASNC Expert Consensus document has appeared on the role of FDG-PET in CS. Recent advances in the field have focused on the role of PET for diagnosis, assessment of therapy, and use of non-FDG tracers to image myocardial inflammation. Summary: The role of PET is rapidly evolving but is now firmly established as an important component in the imaging assessment of CS. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.

引用

共 42 条

[1]

Judson M.A., Boan A.D., Lackland D.T., The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States, Sarcoidosis Vasc Diffuse Lung Dis, 29, pp. 119-127, (2012)

[2]

Nery P.B., Beanlands R.S., Nair G.M., Green M., Yang J., Mcardle B.A., Et al., Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults, J Cardiovasc Electrophysiol, 25, pp. 875-881, (2014)

[3]

Nery P.B., Keren A., Healey J., Leug E., Beanlands R.S., Birnie D.H., Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy, Can J Cardiol, 29, 8, pp. 1015.e1-1015.e3, (2013)

[4]

Birnie D.H., Sauer W.H., Bogun F., Cooper J.M., Culver D.A., Duvernoy C.S., Et al., HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis, Heart Rhythm, 11, pp. 1304-1323, (2014)

[5]

Pelletier-Galarneau M., Ardle B.M., Ohira H., Leung E., Ruddy T.D., Role of PET/CT in assessing cardiac sarcoidosis. Mol Multimodality Imaging Cardiovasc Dis Springer International Publishing

[6]

2015. p. 49–78, DOI

[7]

Youssef G., Leung E., Mylonas I., Nery P., Williams K., Wisenberg G., Et al., The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience, J Nucl Med, 53, pp. 241-248, (2012)

[8]

Chareonthaitawee P., Beanlands R.S., Chen W., Dorbala S., Miller E.J., Murthy V.L., Et al., Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring, J Nucl Med, 58, pp. 1341-1353, (2017)

[9]

Blankstein R., Osborne M., Naya M., Waller A., Kim C.K., Murthy V.L., Et al., Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis, J Am Coll Cardiol, 63, pp. 329-336, (2014)

[10]

Ambrosini V., Zompatori M., Fasano L., Nanni C., Nava S., Rubello D., Fanti S., 18F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study, Clin Nucl Med, 38, pp. e171-e177, (2013)

← 1 2 3 4 5 →